Introduction
Infection with Helicobacter pylori (H. pylori) is the most common chronic bacterial infection in human. H. pylori infection has been detected worldwide and among all age groups. Conservative estimates suggest that 50% of the world's population is infected. Infection is more frequent and acquired at an earlier age in developing countries compared to industrialized nations. Once acquired, infection persists and may or may not cause gastrointestinal disease. 1 The possible role of H. pylori infection in extra-intestinal diseases such as idiopathic thrombocytopenia purpura, acute coronary heart disease, Alzheimer disease, and even patients with epilepsy has been investigated and suggested. [2] [3] [4] [5] [6] The possible reason that H. pylori infection causes or relates to extra-intestinal diseases could be due to immunological mechanisms involved. 4 It has been speculated that, H. pylori, by inducing pro-inflammatory cytokine [interleukin (IL)-1 and -6, or tumor necrosis factor (TNF)-a] production and blood-brain barrier disruption, might influence the pathophysiology and therefore the management of epilepsy. 7 On the other hand, for many patients with epilepsy no certain cause for seizure could be found, even after extensive investigations. The situation in these patients is considered as idiopathic. An idiopathic epilepsy syndrome is usually presumed to be genetic, 8 however other unidentified, unknown causes could not be ruled out yet.
The main purpose of this study was to determine the frequency of infection with H. pylori among two groups of patients with epilepsy: patients with idiopathic generalized epilepsy (IGE) and patients with temporal lobe epilepsy (TLE) due to mesial temporal sclerosis.
Methods and materials
In this cross-sectional study a random sample of adult patients above 18 years of age with an electro-clinical diagnosis of IGE or TLE were recruited at the outpatient epilepsy clinic at Shiraz University of Medical Sciences, which is the only epilepsy clinic in 
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south Iran, from January 2009 through June 2011. The diagnosis of epilepsy was made based on the clinical grounds and EEG findings, and all patients had to be under the care of the epileptologist at our institution. Patients with IGE had absences, myoclonic jerks or generalized tonic-clonic seizures, alone or in combination and their EEG showed spike-wave complexes and/or polyspikes. Patients with TLE had the typical semiology and their EEG showed temporal epileptiform discharges. MRI was available in patients with TLE and showed mesial temporal sclerosis in all. A group of healthy individuals (healthy relatives or care-givers of patients with stroke) attending our general neurology clinic in the same time period and with similar socioeconomic status were included as control group. With regard to socioeconomic status, we did not use any particular tool, but we believe that the patients referring to our epilepsy clinic (cases) and the patients referring to our general neurology clinic (their healthy care-givers were controls) have similar socioeconomic status. For all patients and controls a urea breath test (UBT) was requested. None of the participants took any of the medications with possible interaction with UBT (e.g., omeprazol and antibiotics). Age, gender, seizure type(s), EEG findings and final syndromic diagnosis of all patients were registered routinely. Demographic variables and relevant clinical and EEG variables were summarized descriptively to characterize the study population. Statistical analyses were performed using Pearson Chi square test and t-test (Independent Samples Test) to determine potentially significant differences, and a P value less than 0.05 was considered significant. This study was conducted with approval of the Shiraz University of Medical Sciences Review Board. From all the participants an informed consent was obtained.
Results
Thirty-four patients with IGE, 28 patients with TLE and 33 individuals as control were recruited in the study. Among patients with IGE, 27 patients were female (79%) and 7 (21%) were male. Among patients with TLE, 21 patients were female (75%) and 7 (25%) were male. Control group consisted of 24 females (73%) and 9 (27%) males. There were no significant differences between different groups with regard to sex ratio. The mean age was 23 AE 4 years in patients with IGE. The mean age was 30 AE 9 years in patients with TLE. The mean age was 32 AE 10 years in control group. The difference between mean age of patients with TLE was not statistically significant from those in control group (P = 0.3). The mean age was significantly lower in patients with IGE compared to both control (P = 0.0001) and patients with TLE (P = 0.0001).
Among patients with IGE, UBT was positive in 21 individuals (61.8%). Positive UBT was observed in 50% (14 patients) of patients with TLE and 72.7% (24 individuals) in control group. The difference between patients with IGE and control group with regard to positive UBT was not significant (P = 0.3). The difference between patients with TLE and control group with regard to positive UBT was not significant either (P = 0.068). The difference between patients with IGE and patients with TLE with regard to positive UBT was not significant (P = 0.3).
Discussion
Unidentified, unknown causes are responsible for some cases or syndromes of epilepsy and searching for these possible etiologies may help understand and manage these syndromes more successfully. The relationship between chronic H. pylori infection and extra-intestinal diseases is known. This relationship is probably associated with immunological mechanisms. 4, 9 In two previous studies, it was observed that H. pylori infection was more frequent in patients with epilepsy compared to healthy control 4 and patients with other chronic disorders. 5 In the current study, the rate of H. pylori infection was not higher in patients with epilepsy compared to healthy individuals. This contradiction could be due to methodological reasons, at least in part. In both previous studies, the definitions for idiopathic 5 or cryptogenic 4 epilepsy
were not provided adequately and the random nature of those studies were not discussed (if they were). In addition, the previous studies used serology (IgG and IgM) and stool antigen assay for detection of H. pylori infection, but we used UBT. Different studies have found variable sensitivity (50-100%) and specificity (76-96%) for serological tests. The sensitivity and specificity of stool antigen assay are 90-94% and 81-92%, respectively. However, some studies have noted a lower predictive accuracy. The sensitivity and specificity of UBT are approximately 88-98% and 89-100%, respectively. False positive results are therefore uncommon. UBT is considered as alternative gold standard test (compared with histology) for detection of H. pylori infection. [9] [10] [11] [12] The rate of H.
pylori infection was 73% in our control group, which is comparable to a previous study in Iran. In that previous study, the authors reported seroprevalence of H. pylori to be 71% among the general population of Nahavand, in west Iran. 13 In another recent study, it was observed that H. pylori from Iran are similar to others isolated from Western Eurasia and the authors concluded that they can be placed in the previously described HpEurope population. 14 In conclusion, there is still not enough evidence to believe that H. pylori might be a potential therapeutic target in epilepsy, in contrary with that it was hypothesized recently. 7 Despite the fact that searching for unidentified etiologies of seizures in patients with epilepsy is imperative, at the moment there is not enough epidemiological data to support the role of H. pylori infection in epilepsy syndromes, particularly in patients with either idiopathic generalized epilepsy or temporal lobe epilepsy. However, it should be mentioned that a similar H. pylori prevalence between patients with epilepsy and healthy individuals is not sufficient evidence to exclude the possibility that this infection might trigger the appearance or worsens the prognosis of epilepsy either. Further well-designed studies are required to investigate the relationship between H. pylori infection and epilepsy, particularly in patients with refractory seizures.
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